Medistep Healthcare (NSE:MEDISTEP) Cash Flow for Dividends: ₹0.0 Mil (TTM As of Mar. 2025)


NSE:MEDISTEP Medistep Healthcare Ltd NSE:MEDISTEP
30 GF Score
Price ₹19.80
! 2 Warning Signs
View Full Analysis

What is Medistep Healthcare Cash Flow for Dividends?

Medistep Healthcare NSE:MEDISTEP +9.70% 30 Cash Flow for Dividends is ₹0.0 Mil as of Mar. 2025. GuruFocus rates NSE:MEDISTEP with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

Medistep Healthcare's cash flow for dividends for the six months ended in Mar. 2025 was ₹0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Medistep Healthcare Cash Flow for Dividends Related Terms

Medistep Healthcare Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Medistep Healthcare's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medistep Healthcare Cash Flow for Dividends Chart

Medistep Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25
Cash Flow for Dividends
0.00 0.00 0.00 0.00

Medistep Healthcare Semi-Annual Data
Mar22 Mar23 Mar24 Mar25
Cash Flow for Dividends 0.00 0.00 0.00 0.00
NSE:MEDISTEP
30GF Score
Medistep Healthcare Ltd NSE:MEDISTEP
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medistep Healthcare Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₹0.0 Mil mean?
Medistep Healthcare (NSE:MEDISTEP) has a Cash Flow for Dividends of ₹0.0 Mil as of Mar. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Medistep Healthcare and its competitors.
Is Medistep Healthcare's Cash Flow for Dividends too high?
Medistep Healthcare's current Cash Flow for Dividends is ₹0.0 Mil. Overall, Medistep Healthcare has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Medistep Healthcare's Cash Flow for Dividends compare to MCK and CAH?
Medistep Healthcare's Cash Flow for Dividends of ₹0.0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Distribution company?
A good Cash Flow for Dividends depends on the Medical Distribution industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Medistep Healthcare and its competitors. Medistep Healthcare's current Cash Flow for Dividends is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistep Healthcare stock overvalued right now?
Medistep Healthcare (NSE:MEDISTEP) has a current Cash Flow for Dividends of ₹0.0 Mil. The current Cash Flow for Dividends is ₹0.0 Mil. Medistep Healthcare's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Medistep Healthcare (NSE:MEDISTEP), the current Cash Flow for Dividends is ₹0.0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medistep Healthcare Business Description

Address National Highway 8, 05, S. No-245/B, Plot-19, T.P.S. 56, Free Way Trade Center, Near A-One Hotel, Narol Gam, Narol, Daskroi, Ahmadabad, GJ, IND, 382405
Medistep Healthcare Ltd operates in the pharmaceutical and healthcare product sectors. Its business includes manufacturing intimate care and hygiene products such as sanitary pads, as well as nutraceutical products like energy powders. The company also trades a variety of pharmaceutical, surgical, and medical equipment products. Medistep Healthcare's operations focus mainly on the western region of India, particularly in Gujarat. Its Core business activity is divided into the following categories: a) Trading of Pharmaceutical & Surgical products, b) Trading & Manufacturing of Nutraceuticals and Intimate care & hygiene products. The company generates the majority of its revenue from Trading and distribution.
30GF Score

Get the complete analysis for NSE:MEDISTEP

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹19.80
Price